Literature DB >> 21732842

Why do the same drugs look different? Pills, trade dress, and public health.

Jeremy A Greene1, Aaron S Kesselheim.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21732842     DOI： 10.1056/NEJMhle1101722

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  ["Isoappearance": a pressing need for prescribing by active ingredient (official spanish denomination)].

Authors:  F Palacio Lapuente; M A Hernández Rodríguez
Journal:  Aten Primaria       Date:  2011-12       Impact factor: 1.137

2.  The social and economic influences on medication use and misuse.

Authors:  Robert A Aronowitz
Journal:  J Gen Intern Med       Date:  2012-12       Impact factor: 5.128

Review 3.  FDA Policy and Cardiovascular Medicine.

Authors:  Joseph S Ross; Aaron S Kesselheim
Journal:  Circulation       Date:  2015-09-22       Impact factor: 29.690

4.  A Survey of Patients' Perceptions of Pill Appearance and Responses to Changes in Appearance for Four Chronic Disease Medications.

Authors:  Ameet Sarpatwari; Joshua J Gagne; Zhigang Lu; Eric G Campbell; Wendy J Carman; Cheryl L Enger; Sarah K Dutcher; Wenlei Jiang; Aaron S Kesselheim
Journal:  J Gen Intern Med       Date:  2019-01-10       Impact factor: 5.128

5.  Study CAMBIMED: Effects of changes in medication appearance on safety of antihypertensive and hypolipidemic treatments in chronic patients older than 65 years in primary health care.

Authors:  Jesús Mario Arancon-Monge; Alicia de-Castro-Cuenca; Ángel Serrano-Vázquez; Luz Campos-Díaz; Montserrat Díaz-Eraso; Isabel Del Cura-González; Elena Polentinos-Castro; Ricardo Rodríguez-Barrientos
Journal:  BMC Public Health       Date:  2015-03-04       Impact factor: 3.295

6.  Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelines.

Authors:  Nathalie Vernaz; Victoria Rollason; Liene Adlere; Christophe Combescure; Antoine Poncet; Pascal Bonnabry; Jules Desmeules
Journal:  Pharmacol Res Perspect       Date:  2016-04-21

7.  Is the 'blue' colour convention for inhaled reliever medications important? A UK-based survey of healthcare professionals and patients with airways disease.

Authors:  Monica Fletcher; Jane Scullion; John White; Bronwen Thompson; Toby Capstick
Journal:  NPJ Prim Care Respir Med       Date:  2016-11-03       Impact factor: 2.871

8.  Patented drug extension strategies on healthcare spending: a cost-evaluation analysis.

Authors:  Nathalie Vernaz; Guy Haller; François Girardin; Benedikt Huttner; Christophe Combescure; Pierre Dayer; Daniel Muscionico; Jean-Luc Salomon; Pascal Bonnabry
Journal:  PLoS Med       Date:  2013-06-04       Impact factor: 11.069

9.  Which placebo to cure depression? A thought-provoking network meta-analysis.

Authors:  Florian Naudet; Bruno Millet; Philippe Charlier; Jean Michel Reymann; Anne Solène Maria; Bruno Falissard
Journal:  BMC Med       Date:  2013-10-25       Impact factor: 8.775

10.  A drug by any other name: patients' ability to identify medication regimens and its association with adherence and health outcomes.

Authors:  Jennifer L Lenahan; Danielle M McCarthy; Terry C Davis; Laura M Curtis; Marina Serper; Michael S Wolf
Journal:  J Health Commun       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.